Chitkasaem Suwanrath
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chitkasaem Suwanrath has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
Natthicha Chainarong
Department of Obstetrics and Gynecology Faculty of Medicine, Prince of Songkla University Songkhla Thailand
7 shared publicationsSutham Pinjaroen
Department of Obstetrics and Gynecology, Faculty of Medicine Prince of Songkla University Hat Yai Songkhla Thailand
7 shared publicationsKrantarat Peeyananjarassri
Department of Obstetrics and Gynecology, Faculty of Medicine Prince of Songkla University Hat Yai Songkhla Thailand
5 shared publications- Manaphat Suksai
Department of Obstetrics and Gynecology, Faculty of Medicine Prince of Songkla University Songkhla Thailand
5 shared publications - Natthicha Chainarong
Department of Obstetrics and Gynecology, Faculty of Medicine Prince of Songkla University Hat Yai Thailand
4 shared publications - Ninlapa Pruksanusak
Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand
4 shared publications
Latest Publications
- 16 November 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
Pre‐eclampsia screening and prevention: Implementing FIGO guidelines in a Thai population
Objective: To evaluate the real‐world implementation, screening performance, aspirin uptake, and safety of a FIGO (the International Federation of Gynecology & Obstetrics)‐based first‐trimester pre‐eclampsia screening and prevention program. Methods: This retrospective cohort study included women initiating antenatal care before 14 weeks of gestation at a tertiary referral center in southern Thailand from 2021 to 2024. Screening incorporated maternal factors, mean arterial pressure, and uterine artery pulsatility index. Women with a calculated risk of 1:100 or greater were classified as being at high risk and offered aspirin 162 mg nightly. Outcomes included screening coverage, detection rates, aspirin uptake, pregnancy outcomes, and bleeding complications. Results: Among 1713 pregnancies, 71 developed pre‐eclampsia (4.1%), including 49 with severe features. Overall, 1106 women were screened (64.6%), but coverage reached 93.6% by the end of implementation. The screen‐positive rate was 11.3%. Detection rates were 61.7% for overall pre‐eclampsia, 69.6% for delivery before 37 weeks of gestation, 87.5% for delivery before 34 weeks of gestation, and 100% for delivery before 32 weeks of gestation, with false‐positive rates of approximately 9%–11%. Aspirin uptake among screen‐positive women was 99.2%. Pre‐eclampsia was associated with higher rates of cesarean delivery, preterm birth, lower birth weight, and neonatal intensive care unit admission. No eclampsia, placental abruption, maternal intensive care unit admission, maternal death, stillbirth, or neonatal death occurred. After adjustment for potential confounders, aspirin was not associated with the risk of an estimated blood loss of 500 mL or more, and the risk of an estimated blood loss of 1000 mL or more did not differ significantly between groups. Conclusion: FIGO‐based first‐trimester screening was feasible in routine care, with increasing coverage as implementation matured, near‐universal aspirin uptake, and clinically useful detection of preterm pre‐eclampsia. Aspirin use was not significantly associated with severe bleeding.
- 16 November 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
Pre‐eclampsia screening and prevention: Implementing FIGO guidelines in a Thai population
Objective: To evaluate the real‐world implementation, screening performance, aspirin uptake, and safety of a FIGO (the International Federation of Gynecology & Obstetrics)‐based first‐trimester pre‐eclampsia screening and prevention program. Methods: This retrospective cohort study included women initiating antenatal care before 14 weeks of gestation at a tertiary referral center in southern Thailand from 2021 to 2024. Screening incorporated maternal factors, mean arterial pressure, and uterine artery pulsatility index. Women with a calculated risk of 1:100 or greater were classified as being at high risk and offered aspirin 162 mg nightly. Outcomes included screening coverage, detection rates, aspirin uptake, pregnancy outcomes, and bleeding complications. Results: Among 1713 pregnancies, 71 developed pre‐eclampsia (4.1%), including 49 with severe features. Overall, 1106 women were screened (64.6%), but coverage reached 93.6% by the end of implementation. The screen‐positive rate was 11.3%. Detection rates were 61.7% for overall pre‐eclampsia, 69.6% for delivery before 37 weeks of gestation, 87.5% for delivery before 34 weeks of gestation, and 100% for delivery before 32 weeks of gestation, with false‐positive rates of approximately 9%–11%. Aspirin uptake among screen‐positive women was 99.2%. Pre‐eclampsia was associated with higher rates of cesarean delivery, preterm birth, lower birth weight, and neonatal intensive care unit admission. No eclampsia, placental abruption, maternal intensive care unit admission, maternal death, stillbirth, or neonatal death occurred. After adjustment for potential confounders, aspirin was not associated with the risk of an estimated blood loss of 500 mL or more, and the risk of an estimated blood loss of 1000 mL or more did not differ significantly between groups. Conclusion: FIGO‐based first‐trimester screening was feasible in routine care, with increasing coverage as implementation matured, near‐universal aspirin uptake, and clinically useful detection of preterm pre‐eclampsia. Aspirin use was not significantly associated with severe bleeding.
- 26 June 2026
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 45 (11) , 2499-2511
Placental Assessment Using Microvascular Flow Imaging: Reference Ranges and Clinical Application
Objectives: To establish gestational age‐specific reference ranges for the intraplacental vascular index measured using microvascularity‐flow ultrasound software (VI MV ) and to evaluate its variation by placental location, parity, and pregnancy outcome. Methods: This prospective study enrolled 354 singleton pregnancies, of which 243 (68.64%) uncomplicated cases were used to construct reference ranges. A residual bootstrap method with 500 iterations was applied to square‐root–transformed VI MV values, followed by back‐transformation to derive the 5th, 50th, and 95th percentiles with 95% confidence intervals. Group differences were assessed using quantile regression, and associations with Doppler parameters were examined. Results: VI MV increased significantly with advancing gestational age (linear coefficient 1.88, p = .007), following a curvilinear pattern with mild late‐gestation downturn (quadratic coefficient − 0.036, p = .011). Posterior placentas showed slightly higher early values, although this difference was not significant; from 31 weeks onward, anterior placentas demonstrated significantly higher VI MV (mean difference + 15.4, p = .010 at 31–35 weeks; +11.6, p = .003 at 36–40 weeks). Multiparous women showed a modestly higher fitted trajectory and a similar non‐significant trend toward higher birthweight, but parity was not independently associated with VI MV . Pregnancies complicated by maternal disease, hypertensive disorders, or small‐for‐gestational‐age neonates exhibited lower trajectories than uncomplicated pregnancies, although these differences were not statistically significant. VI MV was inversely associated with uterine and umbilical artery pulsatility indices and positively associated with umbilical vein time‐averaged mean velocity. Conclusions: Gestational age–specific VI MV reference ranges were established. VI MV may provide an adjunctive quantitative marker for assessing placental vascular adaptation and identifying pregnancies with altered placental perfusion.
- 26 June 2026
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 45 (11) , 2499-2511
Placental Assessment Using Microvascular Flow Imaging: Reference Ranges and Clinical Application
Objectives: To establish gestational age‐specific reference ranges for the intraplacental vascular index measured using microvascularity‐flow ultrasound software (VI MV ) and to evaluate its variation by placental location, parity, and pregnancy outcome. Methods: This prospective study enrolled 354 singleton pregnancies, of which 243 (68.64%) uncomplicated cases were used to construct reference ranges. A residual bootstrap method with 500 iterations was applied to square‐root–transformed VI MV values, followed by back‐transformation to derive the 5th, 50th, and 95th percentiles with 95% confidence intervals. Group differences were assessed using quantile regression, and associations with Doppler parameters were examined. Results: VI MV increased significantly with advancing gestational age (linear coefficient 1.88, p = .007), following a curvilinear pattern with mild late‐gestation downturn (quadratic coefficient − 0.036, p = .011). Posterior placentas showed slightly higher early values, although this difference was not significant; from 31 weeks onward, anterior placentas demonstrated significantly higher VI MV (mean difference + 15.4, p = .010 at 31–35 weeks; +11.6, p = .003 at 36–40 weeks). Multiparous women showed a modestly higher fitted trajectory and a similar non‐significant trend toward higher birthweight, but parity was not independently associated with VI MV . Pregnancies complicated by maternal disease, hypertensive disorders, or small‐for‐gestational‐age neonates exhibited lower trajectories than uncomplicated pregnancies, although these differences were not statistically significant. VI MV was inversely associated with uterine and umbilical artery pulsatility indices and positively associated with umbilical vein time‐averaged mean velocity. Conclusions: Gestational age–specific VI MV reference ranges were established. VI MV may provide an adjunctive quantitative marker for assessing placental vascular adaptation and identifying pregnancies with altered placental perfusion.
- 13 February 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 174 (1) , 446-453
Severe adverse cardiac events in pregnant women with congenital heart disease at a university hospital in southern Thailand
Objective: This study aimed to evaluate the incidence and characteristics of severe adverse cardiac events (SCEs) in pregnant women with congenital heart disease (CHD), and to determine the proportion and contributing factors of preventable events. Methods: We retrospectively reviewed the medical records of pregnant women with CHD who delivered at Songklanagarind Hospital between January 1, 2006, and December 31, 2024. Pregnancies with an invalid diagnosis, missing essential data, or loss to follow‐up before delivery or termination were excluded. Collected data included baseline clinical and cardiac characteristics, SCEs, obstetric complications, and factors contributing to preventable failures. Results: During the 19‐year period, SCEs occurred in 24.7% (85 of 344) of pregnancies, including six maternal deaths (1.7%). The most common event was deterioration of New York Heart Association functional class by ≥2 levels, followed by congestive heart failure. Most cases (87.1%, 74 of 85) were considered preventable, with contributing factors related to both patients and healthcare providers. Conclusion: The incidence of SCEs in pregnancies with CHD was high, with the majority deemed preventable.
- 13 February 2026
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 174 (1) , 446-453
Severe adverse cardiac events in pregnant women with congenital heart disease at a university hospital in southern Thailand
Objective: This study aimed to evaluate the incidence and characteristics of severe adverse cardiac events (SCEs) in pregnant women with congenital heart disease (CHD), and to determine the proportion and contributing factors of preventable events. Methods: We retrospectively reviewed the medical records of pregnant women with CHD who delivered at Songklanagarind Hospital between January 1, 2006, and December 31, 2024. Pregnancies with an invalid diagnosis, missing essential data, or loss to follow‐up before delivery or termination were excluded. Collected data included baseline clinical and cardiac characteristics, SCEs, obstetric complications, and factors contributing to preventable failures. Results: During the 19‐year period, SCEs occurred in 24.7% (85 of 344) of pregnancies, including six maternal deaths (1.7%). The most common event was deterioration of New York Heart Association functional class by ≥2 levels, followed by congestive heart failure. Most cases (87.1%, 74 of 85) were considered preventable, with contributing factors related to both patients and healthcare providers. Conclusion: The incidence of SCEs in pregnancies with CHD was high, with the majority deemed preventable.
- 4 June 2025
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 44 (10) , 1849-1857
Maternal Adiposity in the First Trimester Pregnancy as a Predictor of Gestational Diabetes Mellitus
Objectives: To evaluate the predictive ability of first‐trimester ultrasound measurements of maternal adiposity for predicting gestational diabetes mellitus (GDM).Methods: Abdominal adiposity measurements by transabdominal ultrasound were performed, including subcutaneous fat thickness (SFT), visceral fat thickness (VFT), and preperitoneal fat thickness (PFT), measured at 3 specific regions: the umbilicus, suprapubic area, and anterior surface of the liver. Two additional values were calculated based on these measurements: total abdominal fat thickness (TAT), which was determined as the sum of SFT1 and VFT, and body fat index (BFI), which was calculated using the formula: BFI = PFT (mm) × SFT3 (mm)/maternal height (cm). Multiple logistic regression and receiver operating characteristic (ROC) analysis were used to evaluate the predictive ability.Results: A total of 330 pregnant women were enrolled with a prevalence of GDM of 23.0%. Multivariate logistic regression analysis showed that none of the fat parameters were significantly associated with GDM. However, for body mass index (BMI) ≥25 kg/m2, only the BFI showed a statistically significant association with GDM (odds ratio [OR] 2.75 [1.54–4.92]), with an area under the ROC curve (AUC) of 0.677. In the subgroup with BMI < 23 kg/m2, only SFT at the umbilicus was significantly associated with GDM (OR 3.21 [1.08–9.53]) using a cut‐off value of ≥15.4 mm, with a sensitivity of 73.7%, a negative predictive value of 93.8%, and an AUC of 0.668.Conclusions: Both BFI and SFT at the umbilical region demonstrate moderate discriminatory predictive performance for this condition across BMI‐stratified subgroups.
- 4 June 2025
- Published by Wiley in Journal of Ultrasound in Medicine
- Vol. 44 (10) , 1849-1857
Maternal Adiposity in the First Trimester Pregnancy as a Predictor of Gestational Diabetes Mellitus
Objectives: To evaluate the predictive ability of first‐trimester ultrasound measurements of maternal adiposity for predicting gestational diabetes mellitus (GDM).Methods: Abdominal adiposity measurements by transabdominal ultrasound were performed, including subcutaneous fat thickness (SFT), visceral fat thickness (VFT), and preperitoneal fat thickness (PFT), measured at 3 specific regions: the umbilicus, suprapubic area, and anterior surface of the liver. Two additional values were calculated based on these measurements: total abdominal fat thickness (TAT), which was determined as the sum of SFT1 and VFT, and body fat index (BFI), which was calculated using the formula: BFI = PFT (mm) × SFT3 (mm)/maternal height (cm). Multiple logistic regression and receiver operating characteristic (ROC) analysis were used to evaluate the predictive ability.Results: A total of 330 pregnant women were enrolled with a prevalence of GDM of 23.0%. Multivariate logistic regression analysis showed that none of the fat parameters were significantly associated with GDM. However, for body mass index (BMI) ≥25 kg/m2, only the BFI showed a statistically significant association with GDM (odds ratio [OR] 2.75 [1.54–4.92]), with an area under the ROC curve (AUC) of 0.677. In the subgroup with BMI < 23 kg/m2, only SFT at the umbilicus was significantly associated with GDM (OR 3.21 [1.08–9.53]) using a cut‐off value of ≥15.4 mm, with a sensitivity of 73.7%, a negative predictive value of 93.8%, and an AUC of 0.668.Conclusions: Both BFI and SFT at the umbilical region demonstrate moderate discriminatory predictive performance for this condition across BMI‐stratified subgroups.
- 12 May 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (5) , e16319
External validation of a risk‐scoring model for predicting adverse perinatal outcomes in pregnancies with fetal growth restriction
Aim: This study aimed to validate the Prince of Songkla University (PSU) risk‐scoring model for predicting adverse perinatal outcomes in pregnancies with an antenatal diagnosis of fetal growth restriction (FGR) in an independent cohort.Methods: A retrospective study was conducted on 121 non‐anomalous singleton pregnancies affected by FGR between July 2022 and April 2024. The predictive performance of the PSU risk‐scoring model, which combines maternal factors and simple ultrasound measurements to predict adverse perinatal outcomes in FGR, was evaluated by applying the original model to this independent cohort. Model variables included a history of hypertensive disorders of pregnancy (HDP) (1 point), chronic hypertension (3 points), HDP (2 points), maternal weight gain <8 kg (1 point), early‐onset FGR (1 point), estimated fetal weight < 5th percentile (2 points), amniotic fluid index <5 cm (3 points), and abnormal umbilical artery Doppler (2 points). Predictive performance was evaluated using area under the receiver operating characteristic curve (AUC). Sensitivity and specificity were calculated at different cut‐off values.Results: Median (interquartile range) gestational age at FGR diagnosis was 29 (22–39) weeks. Adverse perinatal outcomes occurred in 35 cases (28.9%). A cut‐off score of 2 provided the highest sensitivity (85.7%) with a specificity of 51.2% for predicting adverse perinatal outcomes, with an AUC of 0.809 (95% confidence interval 0.714–0.905).Conclusions: This study confirms the predictive performance of the PSU risk‐scoring model for adverse perinatal outcomes in FGR pregnancies, highlighting its potential to identify at‐risk patients for referral, particularly in low‐resource settings.
- 12 May 2025
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 51 (5) , e16319
External validation of a risk‐scoring model for predicting adverse perinatal outcomes in pregnancies with fetal growth restriction
Aim: This study aimed to validate the Prince of Songkla University (PSU) risk‐scoring model for predicting adverse perinatal outcomes in pregnancies with an antenatal diagnosis of fetal growth restriction (FGR) in an independent cohort.Methods: A retrospective study was conducted on 121 non‐anomalous singleton pregnancies affected by FGR between July 2022 and April 2024. The predictive performance of the PSU risk‐scoring model, which combines maternal factors and simple ultrasound measurements to predict adverse perinatal outcomes in FGR, was evaluated by applying the original model to this independent cohort. Model variables included a history of hypertensive disorders of pregnancy (HDP) (1 point), chronic hypertension (3 points), HDP (2 points), maternal weight gain <8 kg (1 point), early‐onset FGR (1 point), estimated fetal weight < 5th percentile (2 points), amniotic fluid index <5 cm (3 points), and abnormal umbilical artery Doppler (2 points). Predictive performance was evaluated using area under the receiver operating characteristic curve (AUC). Sensitivity and specificity were calculated at different cut‐off values.Results: Median (interquartile range) gestational age at FGR diagnosis was 29 (22–39) weeks. Adverse perinatal outcomes occurred in 35 cases (28.9%). A cut‐off score of 2 provided the highest sensitivity (85.7%) with a specificity of 51.2% for predicting adverse perinatal outcomes, with an AUC of 0.809 (95% confidence interval 0.714–0.905).Conclusions: This study confirms the predictive performance of the PSU risk‐scoring model for adverse perinatal outcomes in FGR pregnancies, highlighting its potential to identify at‐risk patients for referral, particularly in low‐resource settings.
- 2 May 2025
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 171 (1) , 281-287
Prediction of cardiac events in pregnant women with cardiac diseases using modified WHO, CARPREG II, and ZAHARA risk assessments in southern Thailand
Objective: This study aimed to compare the predictive performance of three cardiovascular risk assessment models—modified WHO (mWHO) classification, Cardiac Disease in Pregnancy II (CARPREG II), and Zwangerschap bij Aangeboren Hartafwijking (Pregnancy in Women with Congenital Heart Disease; ZAHARA)—in predicting cardiac events among pregnant women with cardiac diseases. Methods: A retrospective review of medical records was conducted for all pregnant women with cardiac diseases who delivered at Songklanagarind Hospital between January 1, 2011, and December 31, 2022. Pregnancies ending in termination or miscarriage before 24 weeks were excluded. The mWHO, CARPREG II, and ZAHARA classifications were applied to each patient, with ZAHARA used only for congenital cardiac diseases. The discriminative ability of each model was evaluated using the area under the receiver operating characteristic curve (AUC). Results: Among 333 pregnancies with cardiac diseases (163 congenital and 170 acquired), 100 (30.0%) experienced cardiac events. The AUCs for predicting cardiac events in all cases were 0.774 (95% confidence interval [CI] 0.719–0.826) for CARPREG II and 0.744 (95% CI 0.689–0.799) for mWHO. In acquired cardiac disease, the AUC for mWHO (0.700 [95% CI 0.621–0.779]) was higher than that for CARPREG II (0.677 [95% CI 0.596–0.758]). For congenital cardiac disease, CARPREG II exhibited the best predictive performance, followed by mWHO and ZAHARA, with AUC values of 0.768 (95% CI 0.658–0.877), 0.754 (95% CI 0.653–0.854), and 0.685 (95% CI 0.563–0.806), respectively. Conclusion: CARPREG II demonstrated the highest predictive performance for cardiac events in pregnant women with all cardiac diseases, while ZAHARA exhibited the lowest predictive performance for congenital cardiac diseases.
- 2 May 2025
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 171 (1) , 281-287
Prediction of cardiac events in pregnant women with cardiac diseases using modified WHO, CARPREG II, and ZAHARA risk assessments in southern Thailand
Objective: This study aimed to compare the predictive performance of three cardiovascular risk assessment models—modified WHO (mWHO) classification, Cardiac Disease in Pregnancy II (CARPREG II), and Zwangerschap bij Aangeboren Hartafwijking (Pregnancy in Women with Congenital Heart Disease; ZAHARA)—in predicting cardiac events among pregnant women with cardiac diseases. Methods: A retrospective review of medical records was conducted for all pregnant women with cardiac diseases who delivered at Songklanagarind Hospital between January 1, 2011, and December 31, 2022. Pregnancies ending in termination or miscarriage before 24 weeks were excluded. The mWHO, CARPREG II, and ZAHARA classifications were applied to each patient, with ZAHARA used only for congenital cardiac diseases. The discriminative ability of each model was evaluated using the area under the receiver operating characteristic curve (AUC). Results: Among 333 pregnancies with cardiac diseases (163 congenital and 170 acquired), 100 (30.0%) experienced cardiac events. The AUCs for predicting cardiac events in all cases were 0.774 (95% confidence interval [CI] 0.719–0.826) for CARPREG II and 0.744 (95% CI 0.689–0.799) for mWHO. In acquired cardiac disease, the AUC for mWHO (0.700 [95% CI 0.621–0.779]) was higher than that for CARPREG II (0.677 [95% CI 0.596–0.758]). For congenital cardiac disease, CARPREG II exhibited the best predictive performance, followed by mWHO and ZAHARA, with AUC values of 0.768 (95% CI 0.658–0.877), 0.754 (95% CI 0.653–0.854), and 0.685 (95% CI 0.563–0.806), respectively. Conclusion: CARPREG II demonstrated the highest predictive performance for cardiac events in pregnant women with all cardiac diseases, while ZAHARA exhibited the lowest predictive performance for congenital cardiac diseases.
- 11 April 2025
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 75 (S1) , 190-197
Analysis of Maternal Near-miss and Mortality with Hematologic Diseases in a Single Quaternary Referral Center in Southern Thailand
Purpose To assess the causes and clinical outcomes of maternal near-misses and mortality associated with hematologic diseases. Methods We retrospectively reviewed the medical records from women who experienced maternal near-misses or mortality attributed to hematological diseases during pregnancy or within 42 days of pregnancy termination, following the World Health Organization criteria, at a single quaternary referral center in Southern Thailand, from 2006 to 2021. Results A total of 109 cases were analyzed, including five maternal deaths and 104 near-miss cases related to hematologic diseases. The median (min–max) maternal age was 29 (14–43) years, with 57.8% of the women being multiparous. The most common hematologic diseases were immune thrombocytopenia (68.8%), acute leukemia (6.4%), and aplastic anemia (6.4%). Of these, 48.6% were diagnosed before pregnancy and 57.8% exhibited a platelet count < 50 × 109/L during the intrapartum period. Acute leukemia was the leading cause of death (3/5). Severe maternal outcomes in cases of immune thrombocytopenia were more frequently observed in women with platelet counts < 50 × 109/L. Conclusion The primary hematologic diseases causing maternal near-miss and mortality were immune thrombocytopenia, acute leukemia, and aplastic anemia. Acute leukemia was the leading cause of death.
- 11 April 2025
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 75 (S1) , 190-197
Analysis of Maternal Near-miss and Mortality with Hematologic Diseases in a Single Quaternary Referral Center in Southern Thailand
Purpose To assess the causes and clinical outcomes of maternal near-misses and mortality associated with hematologic diseases. Methods We retrospectively reviewed the medical records from women who experienced maternal near-misses or mortality attributed to hematological diseases during pregnancy or within 42 days of pregnancy termination, following the World Health Organization criteria, at a single quaternary referral center in Southern Thailand, from 2006 to 2021. Results A total of 109 cases were analyzed, including five maternal deaths and 104 near-miss cases related to hematologic diseases. The median (min–max) maternal age was 29 (14–43) years, with 57.8% of the women being multiparous. The most common hematologic diseases were immune thrombocytopenia (68.8%), acute leukemia (6.4%), and aplastic anemia (6.4%). Of these, 48.6% were diagnosed before pregnancy and 57.8% exhibited a platelet count < 50 × 109/L during the intrapartum period. Acute leukemia was the leading cause of death (3/5). Severe maternal outcomes in cases of immune thrombocytopenia were more frequently observed in women with platelet counts < 50 × 109/L. Conclusion The primary hematologic diseases causing maternal near-miss and mortality were immune thrombocytopenia, acute leukemia, and aplastic anemia. Acute leukemia was the leading cause of death.
- 18 February 2025
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 53 (4) , 753-760
Prevalence and Doppler Indices of Late‐Onset Fetal Growth Restriction at a Single University Hospital in Southern Thailand
Objectives: To evaluate the prevalence of late‐onset fetal growth restriction (FGR), and comprehensively assess maternal and fetal Doppler indices by comparing the Doppler measurements of the uterine artery (UtA), umbilical artery (UA), umbilical vein (UV), middle cerebral artery (MCA), and ductus venosus (DV) between normal and FGR groups.Methods: This prospective study enrolled 306 singleton pregnant women at ≥ 32 weeks' gestation between June 1, 2023 and April 30, 2024. Fetal biometry and Doppler indices were measured via transabdominal ultrasonography by a single operator. The Mann–Whitney U test was used for statistical comparison.Results: Late‐onset FGR prevalence was 4.9% (15/306). The FGR group had a significantly higher UtA pulsatility index (PI) and lower cerebroplacental ratio (CPR), cerebral‐placental‐uterine ratio (CPUR), and UV blood flow normalized for fetal abdominal circumference (UVBF/AC) compared to the normal group.Conclusion: Late‐onset FGR prevalence was approximately 5%. The higher UtA‐PI and lower CPR, CPUR, and UVBF/AC in the FGR group indicated mild placental insufficiency.
- 18 February 2025
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 53 (4) , 753-760
Prevalence and Doppler Indices of Late‐Onset Fetal Growth Restriction at a Single University Hospital in Southern Thailand
Objectives: To evaluate the prevalence of late‐onset fetal growth restriction (FGR), and comprehensively assess maternal and fetal Doppler indices by comparing the Doppler measurements of the uterine artery (UtA), umbilical artery (UA), umbilical vein (UV), middle cerebral artery (MCA), and ductus venosus (DV) between normal and FGR groups.Methods: This prospective study enrolled 306 singleton pregnant women at ≥ 32 weeks' gestation between June 1, 2023 and April 30, 2024. Fetal biometry and Doppler indices were measured via transabdominal ultrasonography by a single operator. The Mann–Whitney U test was used for statistical comparison.Results: Late‐onset FGR prevalence was 4.9% (15/306). The FGR group had a significantly higher UtA pulsatility index (PI) and lower cerebroplacental ratio (CPR), cerebral‐placental‐uterine ratio (CPUR), and UV blood flow normalized for fetal abdominal circumference (UVBF/AC) compared to the normal group.Conclusion: Late‐onset FGR prevalence was approximately 5%. The higher UtA‐PI and lower CPR, CPUR, and UVBF/AC in the FGR group indicated mild placental insufficiency.
- 8 January 2024
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 165 (2) , 813-822
Successful multidisciplinary team management of placenta accreta spectrum disorder: A referral center model in a middle‐income country
Objective: The aim of the study was to evaluate the outcomes of placenta accreta spectrum (PAS) disorder managed by a multidisciplinary care team (MCT) compared with a conventional care team (CCT) in a PAS referral center in Thailand.Methods: This retrospective single‐center cohort study analyzed PAS management outcomes in the PSU PAS Center between January 2010 and December 2022. The incidence of hemorrhage ≥3500 mL and the composite maternal and neonatal outcomes of PAS were compared before and after the introduction of an MCT in 2016.Results: Of 227 PAS cases, 219 (96.5%) had pathological confirmation. There were 52 (22.9%) cases of placenta accreta, 119 (52.4%) cases of placenta increta, and 56 (24.7%) cases of placenta percreta. The incidence of estimated blood loss (EBL) ≥3500 mL decreased from 61.8% to 34.3% (P < 0.001) after the establishment of the MCT. The median EBL decreased from 4000 (IQR: 2600,7250) mL to 2250 (1300, 4750) mL (P < 0.001). EBL reduction was statistically significant in the accreta and increta groups (P < 0.001). Red blood cell transfusions decreased from five (3, 9) to two (1, 6) units (P < 0.001) per patient. The length of maternal hospital stays and ICU admissions were statistically shorter when PAS was managed by an MCT (P < 0.001). The length of newborn hospital and ICU stays decreased significantly (P < 0.001).Conclusion: The incidence of massive postpartum hemorrhage and a composite of maternal and neonatal morbidities in pregnant women with PAS disorder improved significantly after the establishment of an MCT to manage PAS in a middle‐income country setting.
- 8 January 2024
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 165 (2) , 813-822
Successful multidisciplinary team management of placenta accreta spectrum disorder: A referral center model in a middle‐income country
Objective: The aim of the study was to evaluate the outcomes of placenta accreta spectrum (PAS) disorder managed by a multidisciplinary care team (MCT) compared with a conventional care team (CCT) in a PAS referral center in Thailand.Methods: This retrospective single‐center cohort study analyzed PAS management outcomes in the PSU PAS Center between January 2010 and December 2022. The incidence of hemorrhage ≥3500 mL and the composite maternal and neonatal outcomes of PAS were compared before and after the introduction of an MCT in 2016.Results: Of 227 PAS cases, 219 (96.5%) had pathological confirmation. There were 52 (22.9%) cases of placenta accreta, 119 (52.4%) cases of placenta increta, and 56 (24.7%) cases of placenta percreta. The incidence of estimated blood loss (EBL) ≥3500 mL decreased from 61.8% to 34.3% (P < 0.001) after the establishment of the MCT. The median EBL decreased from 4000 (IQR: 2600,7250) mL to 2250 (1300, 4750) mL (P < 0.001). EBL reduction was statistically significant in the accreta and increta groups (P < 0.001). Red blood cell transfusions decreased from five (3, 9) to two (1, 6) units (P < 0.001) per patient. The length of maternal hospital stays and ICU admissions were statistically shorter when PAS was managed by an MCT (P < 0.001). The length of newborn hospital and ICU stays decreased significantly (P < 0.001).Conclusion: The incidence of massive postpartum hemorrhage and a composite of maternal and neonatal morbidities in pregnant women with PAS disorder improved significantly after the establishment of an MCT to manage PAS in a middle‐income country setting.
- Open Access
- 10 August 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (8) , e0289832
Risk factors for recurrent endometriosis after conservative surgery in a quaternary care center in southern Thailand
Objectives: To determine the 2-year recurrence rate of endometriosis after conservative surgery and the risk factors for recurrence. Methods: This study retrospectively analyzed women with endometriosis who underwent conservative surgery and had at least a 2-year follow-up at a quaternary care hospital in southern Thailand from January 2000 to December 2019. Recurrent endometriosis was defined as either presence of endometrioma with a diameter ≥ 2 cm for more than three consecutive menstrual cycles or relapse of pelvic pain with the same or higher visual analog scale (VAS) score as before surgery. Multivariate logistic regression analysis was used to identify the risk factors for recurrence. Results: The median (interquartile range [IQR]) age was 34 (29, 38) years in 362 cases and nearly three-quarters (74.2%) were nulliparous. Cyclic pain was the most common clinical presentation (48.9%) and the median (IQR) VAS score of pelvic pain was 6 (5, 9). Ovarian cystectomy was the most common procedure (68.1%). The 2-year recurrent endometriosis rate after conservative surgery was 23.2%, and the overall recurrence rate was 56.4%. The risk factors of recurrence were preoperative moderate to severe pelvic pain (adjusted odds ratio [aOR] 1.93; 95% confidence interval [CI], 1.12–3.34; p = 0.017), adhesiolysis/ablation/ovarian cystectomy without unilateral oophorectomy (aOR 2.71; 95% CI, 1.40–5.23; p = 0.002), and duration of postoperative hormonal treatment < 24 months (aOR 10.58; 95% CI, 5.47–20.47; p < 0.001). Conclusion: The 2-year recurrence rate after conservative surgery for endometriosis was 23.2%. Preoperative moderate to severe pelvic pain, procedures except unilateral oophorectomy, and postoperative hormonal treatment < 24 months were risk factors for recurrence.
- 10 August 2023
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (8) , e0289832
Open AccessRisk factors for recurrent endometriosis after conservative surgery in a quaternary care center in southern Thailand
Objectives: To determine the 2-year recurrence rate of endometriosis after conservative surgery and the risk factors for recurrence. Methods: This study retrospectively analyzed women with endometriosis who underwent conservative surgery and had at least a 2-year follow-up at a quaternary care hospital in southern Thailand from January 2000 to December 2019. Recurrent endometriosis was defined as either presence of endometrioma with a diameter ≥ 2 cm for more than three consecutive menstrual cycles or relapse of pelvic pain with the same or higher visual analog scale (VAS) score as before surgery. Multivariate logistic regression analysis was used to identify the risk factors for recurrence. Results: The median (interquartile range [IQR]) age was 34 (29, 38) years in 362 cases and nearly three-quarters (74.2%) were nulliparous. Cyclic pain was the most common clinical presentation (48.9%) and the median (IQR) VAS score of pelvic pain was 6 (5, 9). Ovarian cystectomy was the most common procedure (68.1%). The 2-year recurrent endometriosis rate after conservative surgery was 23.2%, and the overall recurrence rate was 56.4%. The risk factors of recurrence were preoperative moderate to severe pelvic pain (adjusted odds ratio [aOR] 1.93; 95% confidence interval [CI], 1.12–3.34; p = 0.017), adhesiolysis/ablation/ovarian cystectomy without unilateral oophorectomy (aOR 2.71; 95% CI, 1.40–5.23; p = 0.002), and duration of postoperative hormonal treatment < 24 months (aOR 10.58; 95% CI, 5.47–20.47; p < 0.001). Conclusion: The 2-year recurrence rate after conservative surgery for endometriosis was 23.2%. Preoperative moderate to severe pelvic pain, procedures except unilateral oophorectomy, and postoperative hormonal treatment < 24 months were risk factors for recurrence.